domingo, 1 de noviembre de 2026

Children with intense mood swings face greater risk of emotional overeating in adolescence

https://www.news-medical.net/news/20261030/Children-with-intense-mood-swings-face-greater-risk-of-emotional-overeating-in-adolescence.aspx Children with large mood swings are at greater risk for comfort eating in their teens. "Children who often experience strong and variable emotions may be at greater risk of developing emotional overeating later in life," says first author Francesca Parisi, a PhD research fellow at NTNU's Department of Psychology.

FDA approves ILUMYA for adults with active psoriatic arthritis

https://www.news-medical.net/news/20261030/FDA-approves-ILUMYA-for-adults-with-active-psoriatic-arthritis.aspx Sun Pharmaceutical Industries Limited announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ILUMYA® (tildrakizumab-asmn) for the treatment of adults with active psoriatic arthritis (PsA).

Hemoadsorption may improve outcomes in severe poisoning cases

https://www.news-medical.net/news/20261030/Hemoadsorption-may-improve-outcomes-in-severe-poisoning-cases.aspx The WHO estimated over 800,000 suicide deaths in 2012, with poisoning a major concern. Three‑quarters of suicides occur in low‑ and middle‑income countries, with an estimated 30% related to pesticides. Organophosphates account for at least 40% of pesticides in India. For non‑pesticide overdoses, the Extracorporeal Treatment in Poisoning Workgroup (EXTRIP) has reviewed over 20 drugs and toxins and issued recommendations for extracorporeal therapy.

New FAIR Health platform maps chronic disease prevalence across the United States

https://www.news-medical.net/news/20261030/New-FAIR-Health-platform-maps-chronic-disease-prevalence-across-the-United-States.aspx Today, FAIR Health launches FAIR Health Atlas, a free epidemiological reporting platform incorporating data on the commercially insured population. Atlas is an online tool that can provide insights to policy makers, researchers and others wishing to understand chronic disease prevalence trends and geographic variation over time. Drawing on FAIR Health's repository of commercial healthcare claims (the nation's largest), Atlas visualizes chronic disease data across all 50 states and Washington, DC, revealing the areas facing the greatest health challenges. It also includes relevant social determinants of health (SDOH) that influence the risk factors for these diseases.

New database offers insights into psychedelic use outside clinical trials

https://www.news-medical.net/news/20261030/New-database-offers-insights-into-psychedelic-use-outside-clinical-trials.aspx Fireside Project today announced the publication of "The Fireside Database: Large-Scale Evidence from 25,419 Psychedelic Support Interactions" in Science Advances, providing researchers and policymakers with an unprecedented empirical window into psychedelic use and support outside clinical settings.

Skin organoids reveal how herpes simplex virus spreads between cells

https://www.news-medical.net/news/20261030/Skin-organoids-reveal-how-herpes-simplex-virus-spreads-between-cells.aspx Researchers at the Max Delbrück Center and University Medical Center Hamburg-Eppendorf have traced in skin organoids, how herpes simplex virus 1 infection progresses among neighboring skin cells, deepening our understanding. The work was published in Science Advances.

Nanoscale particle shows potential as customizable delivery vehicle for personalized cancer vaccines

https://www.news-medical.net/news/20261030/Nanoscale-particle-shows-potential-as-customizable-delivery-vehicle-for-personalized-cancer-vaccines.aspx A nanoscale particle with a unique structure, developed at MIT, holds potential as a customizable delivery vehicle for personalized cancer vaccines. The backbone of the vaccine is a modified, harmless bacteriophage called M13, which forms a nanofiber that can be coated with cancer antigens. By precisely controlling the density of those cancer proteins, the researchers found that they could create a vaccine that prevents the development of colon tumors in mice.